Sandra Pérez Baos invests at 2048 Ventures, drawing on a decade of research in translational immunology and molecular biology. She helped establish Nucleate New York and worked with NYU’s technology-transfer team while helping launch a therapeutics startup during her postdoctoral fellowship.
Sandra Pérez Baos invests at 2048 Ventures, drawing on a decade of research in translational immunology and molecular biology. She helped establish Nucleate New York and worked with NYU’s technology-transfer team while helping launch a therapeutics startup during her postdoctoral fellowship.
Career
Senior Associate at 2048 Ventures until Present